Data:
{
"symbol": "OCUL",
"price": 10.6532,
"marketCap": 2332624672,
"beta": 0.935,
"lastDividend": 0,
"range": "6.23-16.44",
"change": 0.6132,
"changePercentage": 6.10757,
"volume": 5197713.50031,
"averageVolume": 2714605,
"companyName": "Ocular Therapeutix, Inc.",
"currency": "USD",
"cik": "0001393434",
"isin": "US67576A1007",
"cusip": "67576A100",
"exchangeFullName": "NASDAQ Global Market",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.ocutx.com",
"description": "Ocular Therapeutix, Inc. is a biopharmaceutical company specializing in the creation, advancement, and commercialization of ophthalmic treatments. Their innovative approach leverages a proprietary bioresorbable hydrogel technology to address a range of eye diseases and conditions. The company currently offers two key products: ReSure Sealant, an ophthalmic device designed to prevent fluid leakage from corneal incisions after cataract surgery, and DEXTENZA, a dexamethasone-based ophthalmic insert used to manage post-surgical inflammation and pain in the eye, as well as to treat allergic conjunctivitis. In addition to their commercial offerings, Ocular Therapeutix is actively developing several product candidates in various clinical stages, including: OTX-TKI, an axitinib intravitreal implant in Phase 1 clinical trials for wet age-related macular degeneration (AMD) and other retinal diseases. OTX-TIC, a travoprost intracameral implant, currently in Phase 2 studies for open-angle glaucoma and ocular hypertension. OTX-CSI, a cyclosporine intracanalicular insert that has successfully completed Phase 2 clinical trials for dry eye disease. OTX-DED, a dexamethasone intracanalicular insert undergoing Phase 2 evaluation for the temporary relief of dry eye symptoms. Strategic partnerships are also a significant part of Ocular Therapeutix's operations. This includes a collaboration with Regeneron Pharmaceuticals, Inc. focused on developing and commercializing products that combine Ocular Therapeutix's sustained-release hydrogel technology with Regeneron's large molecule VEGF-targeting compounds for retinal disease treatment. Another partnership with AffaMed Therapeutics Limited covers the development and commercialization of DEXTENZA and OTX-TIC. Additionally, a discovery-focused collaboration with Mosaic Biosciences aims to pinpoint novel targets and therapeutic agents for dry age-related macular degeneration (dAMD). Established in 2006, Ocular Therapeutix, Inc. maintains its headquarters in Bedford, Massachusetts.",
"ceo": "Pravin U. Dugel",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "325",
"phone": "781 357 4000",
"address": "24 Crosby Drive",
"city": "Bedford",
"state": "MA",
"zip": "01730",
"image": "https://images.financialmodelingprep.com/symbol/OCUL.png",
"ipoDate": "2014-07-25",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "OCUL",
"name": "Ocular Therapeutix, Inc.",
"price": 10.6532,
"changePercentage": 6.10757,
"change": 0.6132,
"volume": 5197713.50031,
"dayLow": 10.5,
"dayHigh": 11.16,
"yearHigh": 16.44,
"yearLow": 6.23,
"marketCap": 2332624672,
"priceAvg50": 9.2466,
"priceAvg200": 9.98143,
"exchange": "NASDAQ",
"open": 10.8,
"previousClose": 10.04,
"timestamp": 1786981401,
"chart_vwap_daily": [
{
"t": "2026-07-07",
"v": 10.1889,
"c": 10.33
},
{
"t": "2026-07-08",
"v": 10.1651,
"c": 10.27
},
{
"t": "2026-07-09",
"v": 10.4963,
"c": 10.54
},
{
"t": "2026-07-10",
"v": 10.2125,
"c": 10.2
},
{
"t": "2026-07-13",
"v": 9.8874,
"c": 9.88
},
{
"t": "2026-07-14",
"v": 9.7196,
"c": 9.7
},
{
"t": "2026-07-15",
"v": 9.8664,
"c": 9.96
},
{
"t": "2026-07-16",
"v": 9.1407,
"c": 9.165
},
{
"t": "2026-07-17",
"v": 9.0317,
"c": 8.97
},
{
"t": "2026-07-20",
"v": 8.7612,
"c": 8.71
},
{
"t": "2026-07-21",
"v": 8.9855,
"c": 8.93
},
{
"t": "2026-07-22",
"v": 8.6839,
"c": 8.585
},
{
"t": "2026-07-23",
"v": 8.5447,
"c": 8.62
},
{
"t": "2026-07-24",
"v": 8.5308,
"c": 8.505
},
{
"t": "2026-07-27",
"v": 8.6452,
"c": 8.64
},
{
"t": "2026-07-28",
"v": 8.4356,
"c": 8.45
},
{
"t": "2026-07-29",
"v": 8.4263,
"c": 8.36
},
{
"t": "2026-07-30",
"v": 8.404,
"c": 8.47
},
{
"t": "2026-07-31",
"v": 8.2472,
"c": 8.17
},
{
"t": "2026-08-03",
"v": 8.3425,
"c": 8.4
},
{
"t": "2026-08-04",
"v": 8.5959,
"c": 8.59
},
{
"t": "2026-08-05",
"v": 8.5505,
"c": 8.5
},
{
"t": "2026-08-06",
"v": 8.6434,
"c": 8.74
},
{
"t": "2026-08-07",
"v": 9.0656,
"c": 9.19
},
{
"t": "2026-08-10",
"v": 9.1982,
"c": 9.24
},
{
"t": "2026-08-11",
"v": 9.5968,
"c": 9.76
},
{
"t": "2026-08-12",
"v": 10.172,
"c": 10.23
},
{
"t": "2026-08-13",
"v": 10.1688,
"c": 10.1
},
{
"t": "2026-08-14",
"v": 9.9033,
"c": 10.04
},
{
"t": "2026-08-17",
"v": 10.9115,
"c": 10.665
}
],
"vwap_summary": {
"days": 30,
"days_above": 15,
"days_below": 15,
"pct_days_above": 50,
"position": "below",
"gap_pct": -2.26,
"streak_days": 1
}
}
Data:
{
"volume": 5197713.50031,
"avgVolume": 2714605,
"short_ratio": [
{
"symbol": "OCUL",
"file_date": "2026-08-14",
"date": "20260814",
"short_volume": 272721,
"short_exempt_volume": 0,
"total_volume": 631127,
"short_volume_ratio": 0.4321,
"signal": "Bullish"
}
],
"volume_profile": {
"poc": 8.38,
"vah": 9.81,
"val": 8.16,
"profile": [
{
"price": 8.19,
"volume": 689447
},
{
"price": 8.24,
"volume": 587546
},
{
"price": 8.29,
"volume": 1016156
},
{
"price": 8.33,
"volume": 1801141
},
{
"price": 8.38,
"volume": 3124012
},
{
"price": 8.43,
"volume": 1593767
},
{
"price": 8.48,
"volume": 2882957
},
{
"price": 8.53,
"volume": 1507082
},
{
"price": 8.58,
"volume": 1549957
},
{
"price": 8.63,
"volume": 2327308
},
{
"price": 8.67,
"volume": 1308636
},
{
"price": 8.72,
"volume": 1156896
},
{
"price": 8.77,
"volume": 557725
},
{
"price": 8.82,
"volume": 118771
},
{
"price": 8.87,
"volume": 182530
},
{
"price": 8.92,
"volume": 300427
},
{
"price": 8.96,
"volume": 404128
},
{
"price": 9.01,
"volume": 630576
},
{
"price": 9.06,
"volume": 558116
},
{
"price": 9.11,
"volume": 555872
},
{
"price": 9.16,
"volume": 662317
},
{
"price": 9.21,
"volume": 692456
},
{
"price": 9.26,
"volume": 282254
},
{
"price": 9.3,
"volume": 27403
},
{
"price": 9.35,
"volume": 40277
},
{
"price": 9.4,
"volume": 162678
},
{
"price": 9.45,
"volume": 113383
},
{
"price": 9.5,
"volume": 336925
},
{
"price": 9.55,
"volume": 81584
},
{
"price": 9.59,
"volume": 380289
},
{
"price": 9.64,
"volume": 233987
},
{
"price": 9.69,
"volume": 306838
},
{
"price": 9.74,
"volume": 312073
},
{
"price": 9.79,
"volume": 193752
},
{
"price": 9.84,
"volume": 419175
},
{
"price": 9.89,
"volume": 354421
},
{
"price": 9.93,
"volume": 653050
},
{
"price": 9.98,
"volume": 382564
},
{
"price": 10.03,
"volume": 160181
},
{
"price": 10.08,
"volume": 260797
},
{
"price": 10.13,
"volume": 1423177
},
{
"price": 10.18,
"volume": 535034
},
{
"price": 10.23,
"volume": 494086
},
{
"price": 10.27,
"volume": 938112
},
{
"price": 10.32,
"volume": 665770
},
{
"price": 10.37,
"volume": 719136
},
{
"price": 10.42,
"volume": 0
},
{
"price": 10.47,
"volume": 0
},
{
"price": 10.52,
"volume": 0
},
{
"price": 10.56,
"volume": 0
},
{
"price": 10.61,
"volume": 56692
},
{
"price": 10.66,
"volume": 879465
},
{
"price": 10.71,
"volume": 383315
},
{
"price": 10.76,
"volume": 595452
},
{
"price": 10.81,
"volume": 798593
},
{
"price": 10.86,
"volume": 342924
},
{
"price": 10.9,
"volume": 424274
},
{
"price": 10.95,
"volume": 0
},
{
"price": 11.0,
"volume": 414760
},
{
"price": 11.05,
"volume": 335504
}
],
"sessions": 20
}
}
Data:
{
"symbol": "OCUL",
"marketCap": 2328639600,
"enterpriseValueTTM": 1809381600,
"evToSalesTTM": 34.7597033849464,
"evToOperatingCashFlowTTM": -7.594816969513808,
"evToFreeCashFlowTTM": -7.092832614660917,
"evToEBITDATTM": -6.357831414204947,
"netDebtToEBITDATTM": 1.8245763218091928,
"currentRatioTTM": 13.105035181193314,
"incomeQualityTTM": 0.7903180326889967,
"grahamNumberTTM": null,
"grahamNetNetTTM": 2.0981047157223838,
"taxBurdenTTM": 1,
"interestBurdenTTM": 1.039314724662465,
"workingCapitalTTM": 595253000,
"investedCapitalTTM": 620529000,
"returnOnAssetsTTM": -0.4490382338001272,
"operatingReturnOnAssetsTTM": -0.44721002161205714,
"returnOnTangibleAssetsTTM": -0.4490382338001272,
"returnOnEquityTTM": -0.5986573025690475,
"returnOnInvestedCapitalTTM": -0.5020383365485648,
"returnOnCapitalEmployedTTM": -0.504557633855882,
"earningsYieldTTM": -0.12600355169100796,
"freeCashFlowYieldTTM": -0.10954894007642918,
"capexToOperatingCashFlowTTM": -0.07077346698063709,
"capexToDepreciationTTM": 3.0937614678899084,
"capexToRevenueTTM": 0.3239136281553771,
"salesGeneralAndAdministrativeToRevenueTTM": 2.6077534867637455,
"researchAndDevelopementToRevenueTTM": 4.293791063126753,
"stockBasedCompensationToRevenueTTM": 1.0235716755676798,
"intangiblesToTotalAssetsTTM": 0,
"averageReceivablesTTM": 27304000,
"averagePayablesTTM": 7511000,
"averageInventoryTTM": 3781500,
"daysOfSalesOutstandingTTM": 212.18859261536096,
"daysOfPayablesOutstandingTTM": 380.67084078711986,
"daysOfInventoryOutstandingTTM": 208.18276684555755,
"operatingCycleTTM": 420.3713594609185,
"cashConversionCycleTTM": 39.700518673798626,
"freeCashFlowToEquityTTM": -255100000,
"freeCashFlowToFirmTTM": -243697000,
"tangibleAssetValueTTM": 520041000,
"netCurrentAssetValueTTM": 493151000,
"grossProfitMarginTTM": 0.8711338225688708,
"ebitMarginTTM": -5.571982940792254,
"ebitdaMarginTTM": -5.467226341875745,
"operatingProfitMarginTTM": -6.030410727321628,
"pretaxProfitMarginTTM": -5.791043915933454,
"continuousOperationsProfitMarginTTM": -5.791043915933454,
"netProfitMarginTTM": -5.791043915933454,
"bottomLineProfitMarginTTM": -5.791043915933454,
"receivablesTurnoverTTM": 1.7201678728396286,
"payablesTurnoverTTM": 0.9588336192109777,
"inventoryTurnoverTTM": 1.753267119707266,
"fixedAssetTurnoverTTM": 2.0594239594872605,
"assetTurnoverTTM": 0.0775401189006088,
"quickRatioTTM": 13.027229836905683,
"solvencyRatioTTM": -1.9566487744255532,
"cashRatioTTM": 12.173933379428153,
"priceToEarningsRatioTTM": -7.48943661971831,
"priceToEarningsGrowthRatioTTM": 0.6597859438213204,
"forwardPriceToEarningsGrowthRatioTTM": 7.144061462902462,
"priceToEarningsDilutedRatioTTM": -7.48943661971831,
"priceToEarningsDilutedGrowthRatioTTM": 0.6597859438213204,
"priceToBookRatioTTM": 4.600347033753108,
"priceToSalesRatioTTM": 44.73507511430437,
"priceToFreeCashFlowRatioTTM": -9.12834025872207,
"priceToOperatingCashFlowRatioTTM": -10.041886810219989,
"debtToAssetsRatioTTM": 0.11824964956942845,
"debtToEquityRatioTTM": 0.15264757971006132,
"debtToCapitalRatioTTM": 0.13243213484945549,
"longTermDebtToCapitalRatioTTM": 0.12279112604497702,
"financialLeverageRatioTTM": 1.2908924488646087,
"workingCapitalTurnoverRatioTTM": 0.0830495427042076,
"operatingCashFlowRatioTTM": -4.8448163663724735,
"operatingCashFlowSalesRatioTTM": -4.576766434856111,
"freeCashFlowOperatingCashFlowRatioTTM": 1.070773466980637,
"debtServiceCoverageRatioTTM": -19.59318416523236,
"interestCoverageRatioTTM": -27.528457423485047,
"shortTermOperatingCashFlowCoverageRatioTTM": -76.30973734785394,
"operatingCashFlowCoverageRatioTTM": -3.0011337440006045,
"capitalExpenditureCoverageRatioTTM": -14.129588992349209,
"dividendPaidAndCapexCoverageRatioTTM": -14.129588992349209,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 0.2314000362778925,
"netIncomePerShareTTM": -1.3400477722338697,
"interestDebtPerShareTTM": 0.40357866241834917,
"cashPerShareTTM": 2.661189324882504,
"bookValuePerShareTTM": 2.311782115994765,
"tangibleBookValuePerShareTTM": 2.311782115994765,
"shareholdersEquityPerShareTTM": 2.311782115994765,
"operatingCashFlowPerShareTTM": -1.0590639190611448,
"capexPerShareTTM": 0.07495362530605805,
"freeCashFlowPerShareTTM": -1.134017544367203,
"netIncomePerEBTTTM": 1,
"ebtPerEbitTTM": 0.9603067150461762,
"priceToFairValueTTM": 4.600347033753108,
"debtToMarketCapTTM": 0.03260143819593208,
"effectiveTaxRateTTM": 0,
"enterpriseValueMultipleTTM": -6.357831414204947,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 51823000
}
],
"dcf": {
"symbol": "OCUL",
"date": "2026-08-16",
"dcf": -0.46008297974722845,
"Stock Price": 10.04
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "OCUL",
"reportedCurrency": "USD",
"cik": "0001393434",
"filingDate": "2026-02-05",
"acceptedDate": "2026-02-05 07:58:16",
"fiscalYear": "2025",
"period": "FY",
"revenue": 51823000,
"costOfRevenue": 6574000,
"grossProfit": 45249000,
"researchAndDevelopmentExpenses": 197096000,
"generalAndAdministrativeExpenses": 64376000,
"sellingAndMarketingExpenses": 53922000,
"sellingGeneralAndAdministrativeExpenses": 118298000,
"otherExpenses": 0,
"operatingExpenses": 315394000,
"costAndExpenses": 321968000,
"netInterestIncome": 6520000,
"interestIncome": 18355000,
"interestExpense": 11835000,
"depreciationAndAmortization": 4323000,
"ebitda": -249781000,
"ebit": -254104000,
"nonOperatingIncomeExcludingInterest": -15913000,
"operatingIncome": -270017000,
"totalOtherIncomeExpensesNet": 4078000,
"incomeBeforeTax": -265939000,
"incomeTaxExpense": 0,
"netIncomeFromContinuingOperations": -265939000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -265939000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -265939000,
"eps": -1.42,
"epsDiluted": -1.42,
"weightedAverageShsOut": 187241483,
"weightedAverageShsOutDil": 187241483
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "OCUL",
"reportedCurrency": "USD",
"cik": "0001393434",
"filingDate": "2026-02-05",
"acceptedDate": "2026-02-05 07:58:16",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 737060000,
"shortTermInvestments": 0,
"cashAndShortTermInvestments": 737060000,
"netReceivables": 30650000,
"accountsReceivables": 30650000,
"otherReceivables": 0,
"inventory": 3564000,
"prepaids": 0,
"otherCurrentAssets": 10855000,
"totalCurrentAssets": 782129000,
"propertyPlantEquipmentNet": 24314000,
"goodwill": 0,
"intangibleAssets": 0,
"goodwillAndIntangibleAssets": 0,
"longTermInvestments": 1614000,
"taxAssets": 0,
"otherNonCurrentAssets": 0,
"totalNonCurrentAssets": 25928000,
"otherAssets": 0,
"totalAssets": 808057000,
"totalPayables": 4154000,
"accountPayables": 4154000,
"otherPayables": 0,
"accruedExpenses": 17971000,
"shortTermDebt": 2817000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 25864000,
"totalCurrentLiabilities": 50806000,
"longTermDebt": 74151000,
"capitalLeaseObligationsNonCurrent": 2815000,
"deferredRevenueNonCurrent": 14000000,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 11975000,
"totalNonCurrentLiabilities": 102941000,
"otherLiabilities": 0,
"capitalLeaseObligations": 2815000,
"totalLiabilities": 153747000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 22000,
"retainedEarnings": -1157023000,
"additionalPaidInCapital": 1811311000,
"accumulatedOtherComprehensiveIncomeLoss": 0,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 654310000,
"totalEquity": 654310000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 808057000,
"totalInvestments": 1614000,
"totalDebt": 79783000,
"netDebt": -657277000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "OCUL",
"reportedCurrency": "USD",
"cik": "0001393434",
"filingDate": "2026-02-05",
"acceptedDate": "2026-02-05 07:58:16",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -265939000,
"depreciationAndAmortization": 4323000,
"deferredIncomeTax": 0,
"stockBasedCompensation": 43184000,
"changeInWorkingCapital": 7710000,
"accountsReceivables": 1738000,
"inventory": -524000,
"accountsPayables": -887000,
"otherWorkingCapital": 7383000,
"otherNonCashItems": 5839000,
"netCashProvidedByOperatingActivities": -204883000,
"investmentsInPropertyPlantAndEquipment": -12010000,
"acquisitionsNet": 0,
"purchasesOfInvestments": 0,
"salesMaturitiesOfInvestments": 0,
"otherInvestingActivities": 130000,
"netCashProvidedByInvestingActivities": -11880000,
"netDebtIssuance": 0,
"longTermNetDebtIssuance": 0,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 561721000,
"netCommonStockIssuance": 561721000,
"commonStockIssuance": 561721000,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": 0,
"netCashProvidedByFinancingActivities": 561721000,
"effectOfForexChangesOnCash": 0,
"netChangeInCash": 344958000,
"cashAtEndOfPeriod": 738674000,
"cashAtBeginningOfPeriod": 393716000,
"operatingCashFlow": -204883000,
"capitalExpenditure": -12010000,
"freeCashFlow": -216893000,
"incomeTaxesPaid": 0,
"interestPaid": 9029000
}
]
}
}
Data:
{
"price": 10.655,
"rsi": 69.63319958066461,
"sma20": 9.009249999999998,
"sma50": 9.2839,
"sma200": 9.977125000000006,
"adx": 24.535659217768313,
"atr": 0.45,
"atr_pct": 4.22,
"high_52w": 16.11,
"low_52w": 2.08,
"structure": {
"ema8": 9.835347379898367,
"ema21": 9.380260062638621,
"ema50": 9.252694985476104,
"ema200": 9.598388715184676,
"checks": {
"price_above_all": true,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": false,
"adx_over_30": false,
"higher_highs_lows": true,
"near_21ema": false
},
"dist_21ema_pct": 13.6,
"macd": {
"macd": 0.267,
"signal": 0.032,
"histogram": 0.235
},
"bollinger": {
"mid": 9.01,
"upper": 10.45,
"lower": 7.57,
"width_pct": 32.06
},
"crossover": {
"fresh_cross": true,
"pre_compressed": false,
"held_above_21": true,
"candles_since": 4,
"intraday_support": false
},
"momentum": {
"roc10": 26.8,
"checks": {
"roc_over_5": true,
"rsi_in_band": true,
"macd_expanding": true,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": false
},
"volume": {
"rvol": 2.3,
"checks": {
"rvol_over_2": true,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": true,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 2.97,
"checks": {
"beats_spy_all": true,
"beats_sector_10d": true,
"rs_line_at_high": true,
"sector_top3": false
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": false,
"avg_vol_over_2m": true,
"mcap_over_1b": true,
"no_earnings_7d": true,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": true
},
"avg_dollar_vol": 28919229.986,
"avg_vol": 2714605
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": false,
"oi_calls_above_price": true
},
"vals": {
"call_vol_mult": 1.0,
"iv_rank": 7.0
}
}
}
}
Data:
{
"prior_day": {
"high": 11.16,
"low": 10.5,
"close": 10.66,
"date": "2026-08-17"
},
"woodie_pivots": {
"PP": 10.75,
"R1": 10.99,
"S1": 10.33,
"R2": 11.41,
"S2": 10.09
},
"swing": {
"high_20d": 11.16,
"low_20d": 8.15,
"high_60d": 11.16,
"low_60d": 7.86
},
"orb": {
"high": 11.07,
"low": 10.5,
"date": "2026-08-17"
},
"vwap": 10.83,
"volume_profile": {
"poc": 8.38,
"vah": 9.81,
"val": 8.16,
"sessions": 20
},
"recent_daily": [
{
"d": "2026-07-14",
"o": 9.87,
"h": 9.9798,
"l": 9.63,
"c": 9.7,
"v": 1427317.481542
},
{
"d": "2026-07-15",
"o": 9.68,
"h": 10.045,
"l": 9.4824,
"c": 9.96,
"v": 1322841.105647
},
{
"d": "2026-07-16",
"o": 9.9,
"h": 9.935,
"l": 8.87,
"c": 9.165,
"v": 2719495.431814
},
{
"d": "2026-07-17",
"o": 9.07,
"h": 9.215,
"l": 8.8101,
"c": 8.97,
"v": 1880853.309516
},
{
"d": "2026-07-20",
"o": 8.95,
"h": 9.15,
"l": 8.63,
"c": 8.71,
"v": 2496875.75118
},
{
"d": "2026-07-21",
"o": 8.7,
"h": 9.135,
"l": 8.67,
"c": 8.93,
"v": 1584522.188551
},
{
"d": "2026-07-22",
"o": 8.84,
"h": 8.89,
"l": 8.58,
"c": 8.585,
"v": 1865677.268079
},
{
"d": "2026-07-23",
"o": 8.5,
"h": 8.68,
"l": 8.32,
"c": 8.62,
"v": 1811982.761586
},
{
"d": "2026-07-24",
"o": 8.66,
"h": 8.705,
"l": 8.43,
"c": 8.505,
"v": 1166170.246666
},
{
"d": "2026-07-27",
"o": 8.64,
"h": 8.86,
"l": 8.475,
"c": 8.64,
"v": 1539831.034919
},
{
"d": "2026-07-28",
"o": 8.61,
"h": 8.665,
"l": 8.305,
"c": 8.45,
"v": 2373435.136873
},
{
"d": "2026-07-29",
"o": 8.51,
"h": 8.61,
"l": 8.295,
"c": 8.36,
"v": 1785320.094241
},
{
"d": "2026-07-30",
"o": 8.37,
"h": 8.53,
"l": 8.27,
"c": 8.47,
"v": 2686427.348764
},
{
"d": "2026-07-31",
"o": 8.44,
"h": 8.564,
"l": 8.15,
"c": 8.17,
"v": 2151848.568854
},
{
"d": "2026-08-03",
"o": 8.285,
"h": 8.495,
"l": 8.175,
"c": 8.4,
"v": 3327377.963819
},
{
"d": "2026-08-04",
"o": 8.4,
"h": 8.715,
"l": 8.355,
"c": 8.59,
"v": 2231589.05527
},
{
"d": "2026-08-05",
"o": 8.68,
"h": 8.79,
"l": 8.45,
"c": 8.5,
"v": 1599949.893177
},
{
"d": "2026-08-06",
"o": 8.45,
"h": 8.79,
"l": 8.4,
"c": 8.74,
"v": 1594002.025313
},
{
"d": "2026-08-07",
"o": 8.8,
"h": 9.2,
"l": 8.8,
"c": 9.19,
"v": 2016649.659794
},
{
"d": "2026-08-10",
"o": 9.2,
"h": 9.305,
"l": 9.04,
"c": 9.24,
"v": 1529755.720206
},
{
"d": "2026-08-11",
"o": 9.29,
"h": 9.77,
"l": 9.16,
"c": 9.76,
"v": 2180219.406116
},
{
"d": "2026-08-12",
"o": 9.77,
"h": 10.43,
"l": 9.74,
"c": 10.23,
"v": 4006398.268135
},
{
"d": "2026-08-13",
"o": 10.27,
"h": 10.43,
"l": 10.075,
"c": 10.1,
"v": 2584839.539418
},
{
"d": "2026-08-14",
"o": 10.04,
"h": 10.07,
"l": 9.68,
"c": 10.04,
"v": 1634137.148678
},
{
"d": "2026-08-17",
"o": 10.8,
"h": 11.16,
"l": 10.5,
"c": 10.665,
"v": 5188357.500306
}
]
}
Data:
{
"estimates": [
{
"symbol": "OCUL",
"date": "2030-12-31",
"revenueLow": 560296755,
"revenueHigh": 1683968960,
"revenueAvg": 991014000,
"ebitdaLow": -1327527186,
"ebitdaHigh": -441700050,
"ebitdaAvg": -781248383,
"ebitLow": -1346262028,
"ebitHigh": -447933580,
"ebitAvg": -792273818,
"netIncomeLow": 90896378,
"netIncomeHigh": 398908619,
"netIncomeAvg": 208961496,
"sgaExpenseLow": 908117456,
"sgaExpenseHigh": 2729342255,
"sgaExpenseAvg": 1606215108,
"epsAvg": 1.116,
"epsHigh": 2.13045,
"epsLow": 0.48545,
"numAnalystsRevenue": 3,
"numAnalystsEps": 2
},
{
"symbol": "OCUL",
"date": "2029-12-31",
"revenueLow": 359726259,
"revenueHigh": 1081155387,
"revenueAvg": 636258833,
"ebitdaLow": -852309753,
"ebitdaHigh": -283583842,
"ebitdaAvg": -501583413,
"ebitLow": -864338048,
"ebitHigh": -287585944,
"ebitAvg": -508662052,
"netIncomeLow": 1628965,
"netIncomeHigh": 7148917,
"netIncomeAvg": 3744829,
"sgaExpenseLow": 583036922,
"sgaExpenseHigh": 1752314414,
"sgaExpenseAvg": 1031235230,
"epsAvg": 0.02,
"epsHigh": 0.0381802,
"epsLow": 0.00869981,
"numAnalystsRevenue": 4,
"numAnalystsEps": 3
},
{
"symbol": "OCUL",
"date": "2028-12-31",
"revenueLow": 101129479,
"revenueHigh": 467581805,
"revenueAvg": 286834167,
"ebitdaLow": -368609857,
"ebitdaHigh": -79723638,
"ebitdaAvg": -226120649,
"ebitLow": -373811895,
"ebitHigh": -80848745,
"ebitAvg": -229311796,
"netIncomeLow": -349104257,
"netIncomeHigh": -85378371,
"netIncomeAvg": -238990000,
"sgaExpenseLow": 163908579,
"sgaExpenseHigh": 757846972,
"sgaExpenseAvg": 464894918,
"epsAvg": -1.01667,
"epsHigh": -0.45598,
"epsLow": -1.86446,
"numAnalystsRevenue": 6,
"numAnalystsEps": 6
},
{
"symbol": "OCUL",
"date": "2027-12-31",
"revenueLow": 65057763,
"revenueHigh": 205447930,
"revenueAvg": 100660064,
"ebitdaLow": -161961246,
"ebitdaHigh": -51287138,
"ebitdaAvg": -79353583,
"ebitLow": -164246938,
"ebitHigh": -52010932,
"ebitAvg": -80473467,
"netIncomeLow": -341034149,
"netIncomeHigh": -153159789,
"netIncomeAvg": -305210000,
"sgaExpenseLow": 105444284,
"sgaExpenseHigh": 332985779,
"sgaExpenseAvg": 163147761,
"epsAvg": -1.49417,
"epsHigh": -0.81798,
"epsLow": -1.82136,
"numAnalystsRevenue": 8,
"numAnalystsEps": 7
}
],
"price_target": {
"symbol": "OCUL",
"targetHigh": 30,
"targetLow": 25,
"targetConsensus": 27.5,
"targetMedian": 27.5
},
"ratings": {
"symbol": "OCUL",
"rating": "C-",
"overallScore": 1,
"discountedCashFlowScore": 1,
"returnOnEquityScore": 1,
"returnOnAssetsScore": 1,
"debtToEquityScore": 3,
"priceToEarningsScore": 1,
"priceToBookScore": 2
},
"grades": [
{
"symbol": "OCUL",
"date": "2026-08-04",
"gradingCompany": "Chardan Capital",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2026-06-25",
"gradingCompany": "Chardan Capital",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2026-06-18",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2026-06-18",
"gradingCompany": "Baird",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2026-05-06",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2026-05-05",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2026-04-13",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2026-03-03",
"gradingCompany": "Clear Street",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2026-02-20",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2026-02-18",
"gradingCompany": "Chardan Capital",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2025-12-09",
"gradingCompany": "Chardan Capital",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2025-12-08",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2025-12-08",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2025-11-25",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2025-11-05",
"gradingCompany": "Chardan Capital",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2025-10-30",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2025-10-08",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2025-10-03",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2025-10-03",
"gradingCompany": "Baird",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2025-10-02",
"gradingCompany": "Chardan Capital",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2025-10-01",
"gradingCompany": "JMP Securities",
"previousGrade": "Market Outperform",
"newGrade": "Market Outperform",
"action": "maintain"
},
{
"symbol": "OCUL",
"date": "2025-10-01",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Why is Ocular Therapeutix stock rallying today? By Investing.com",
"url": "https://www.investing.com/news/stock-market-news/why-is-ocular-therapeutix-stock-rallying-today-93CH-4863517",
"source": "Investing.com",
"date": "2026-08-17T14:41:05Z",
"summary": "Investing.com -- Ocular Therapeutix stock rose 6.3% in morning trading after competitor EyePoint Pharmaceuticals announced that its DURAVYU (vorolanib intravitreal insert) failed to achieve the primary endpoint in the pivotal Phase 3 LUGANO clinical trial for wet age-related macu",
"image": "https://content-media.investing.com/news/LYNXNPEB7Q0U9_L.jpg"
},
{
"title": "SpaceX and Micron Tech among market cap stock movers on Monday By Investing.com",
"url": "https://www.investing.com/news/stock-market-news/spacex-and-micron-tech-among-market-cap-stock-movers-on-monday-93CH-4863504",
"source": "Investing.com",
"date": "2026-08-17T14:31:19Z",
"summary": "Monday's market has seen swings in various stocks based on news and other factors. Today, stocks like SpaceX and Micron Tech are rallying, while stocks like Dell Inc are falling. Below are highlights of some of the biggest stock movers, from mega-caps to small caps.\n\nMega-Cap Mov",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM4P1G2_L.jpg"
},
{
"title": "Ocular Therapeutix stock rises as rival's wet AMD trial stumbles By Investing.com",
"url": "https://www.investing.com/news/stock-market-news/ocular-therapeutix-stock-rises-as-rivals-wet-amd-trial-stumbles-93CH-4863480",
"source": "Investing.com",
"date": "2026-08-17T14:18:04Z",
"summary": "Investing.com -- Ocular Therapeutix Inc (NASDAQ:OCUL) shares rose 7.5% Monday after competitor EyePoint Pharmaceuticals (NASDAQ:EYPT) announced its DURAVYU treatment missed the primary endpoint in a pivotal Phase 3 wet AMD trial.\n\nEyePoint reported that DURAVYU failed to achieve ",
"image": "https://content-media.investing.com/news/LYNXNPEB8506G_L.jpg"
},
{
"title": "H World Group Posts Upbeat Q2 Results, Joins Almonty Industries, Diana Shipping And Other Big Stocks Moving Higher On Monday",
"url": "https://www.benzinga.com/trading-ideas/movers/26/08/61247435/h-world-group-posts-upbeat-q2-results-joins-almonty-industries-diana-shipping-and-other-big-stocks-moving-higher-on-monday",
"source": "benzinga",
"date": "2026-08-17T13:51:57.624000+00:00",
"summary": "H World Group (HTHT) beats earnings and raises sales guidance, shares jump 8.1%. Other big gainers include ANGX, ARGX, and MESO.",
"image": ""
},
{
"title": "12 Health Care Stocks Moving In Monday's Pre-Market Session",
"url": "https://www.benzinga.com/trading-ideas/movers/26/08/61243333/12-health-care-stocks-moving-monday-s-pre-market-session",
"source": "benzinga",
"date": "2026-08-17T12:06:31.187000+00:00",
"summary": "Gainers\n\nINVO Fertility (NASDAQ:IVF) shares increased by 163.4% to $2.56 during Monday's pre-market session. The company's market cap stands at $1.7 million. \nGlucoTrack (NASDAQ:GCTK) shares moved upwards by",
"image": ""
},
{
"title": "Ocular Therapeutix\u2122 Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)",
"url": "https://www.globenewswire.com/news-release/2026/08/13/3344910/0/en/ocular-therapeutix-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html",
"source": "GlobeNewsWire",
"date": "2026-08-13 16:05:00",
"summary": "BEDFORD, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, \u201cOcular\u201d or the \u201cCompany\u201d), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to Ms. Beth Rada, the",
"image": "https://images.financialmodelingprep.com/news/ocular-therapeutix-reports-inducement-grants-under-nasdaq-listing-rule-20260813.jpg"
},
{
"title": "California State Teachers Retirement System Increases Stock Position in Ocular Therapeutix, Inc. $OCUL",
"url": "https://www.defenseworld.net/2026/08/13/california-state-teachers-retirement-system-increases-stock-position-in-ocular-therapeutix-inc-ocul.html",
"source": "Defense World",
"date": "2026-08-13 03:50:46",
"summary": "California State Teachers Retirement System increased its holdings in Ocular Therapeutix, Inc. (NASDAQ: OCUL) by 41.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 213,706 shares of the biopharmace",
"image": "https://images.financialmodelingprep.com/news/california-state-teachers-retirement-system-increases-stock-position-in-20260813.jpg"
},
{
"title": "Ocular Therapeutix: AXPAXLI Can Turn Retina Capacity Into A Commercial Moat",
"url": "https://seekingalpha.com/article/4930814-ocular-therapeutix-axpaxli-can-turn-retina-capacity-into-a-commercial-moat",
"source": "Seeking Alpha",
"date": "2026-08-05 11:25:44",
"summary": "Ocular Therapeutix (OCUL) is positioned for a potential 2027 launch of AXPAXLI, with a de-risked regulatory path and strong Phase 3 efficacy data. AXPAXLI's annual dosing and clinic productivity benefits could drive adoption beyond wet AMD, targeting broader retinal indications i",
"image": "https://images.financialmodelingprep.com/news/ocular-therapeutix-axpaxli-can-turn-retina-capacity-into-a-20260805.jpg"
},
{
"title": "Ocular Therapeutix\u2122 Reports Second Quarter 2026 Financial Results and Business Highlights",
"url": "https://finance.yahoo.com/healthcare/articles/ocular-therapeutix-reports-second-quarter-110000734.html",
"source": "Yahoo! Finance",
"date": "2026-08-03T11:00:00Z",
"summary": "Ocular's AXPAXLITM wet AMD NDA submission on track for Q4 2026 following positive Type C Meeting with the U.S. FDA in May 2026\n\nFDA Type C Meeting Minutes Formalize SOL-1 Trial with Confirmatory Evidence as Sufficient to Support Submission of AXPAXLI NDA in wet AMD\n\nAXPAXLI NDA s",
"image": "https://s.yimg.com/lo/mysterio/api/5B0513971F32F338BA3FB182D7B1FE98E3D74AD21554E3072C7E633E6BEEBE50/subgraphmysterio/resizefill_w1200_h405;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fglobenewswire.com%2F5fdec8676d63e555e3a776d7e19f838d"
},
{
"title": "Ocular Therapeutix (OCUL) Reports Q2 Loss, Beats Revenue Estimates",
"url": "https://www.zacks.com/stock/news/2966330/ocular-therapeutix-ocul-reports-q2-loss-beats-revenue-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_4-2966330",
"source": "Zacks Investment Research",
"date": "2026-08-03 09:10:22",
"summary": "Ocular Therapeutix (OCUL) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.4. This compares to a loss of $0.39 per share a year ago.",
"image": "https://images.financialmodelingprep.com/news/ocular-therapeutix-ocul-reports-q2-loss-beats-revenue-estimates-20260803.jpg"
},
{
"title": "3 Russell 2000 Stocks That Concern Us",
"url": "https://finance.yahoo.com/markets/stocks/articles/3-russell-2000-stocks-concern-184357653.html",
"source": "Yahoo! Finance",
"date": "2026-07-31T18:43:57Z",
"summary": "The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic d",
"image": "https://s.yimg.com/lo/mysterio/api/472A244D542719DB21BE36C170A362550295C7F99F828D41B03758E3097C646A/subgraphmysterio/resizefill_w1200_h600;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fstockstory_922%2F9c228289b039bd70f8e4f4740f630164"
},
{
"title": "Pharmaceuticals Stocks Q1 In Review: Ocular Therapeutix (NASDAQ:OCUL) Vs Peers",
"url": "https://finance.yahoo.com/healthcare/articles/pharmaceuticals-stocks-q1-review-ocular-014902472.html",
"source": "Yahoo! Finance",
"date": "2026-07-29T01:49:02Z",
"summary": "Let's dig into the relative performance of Ocular Therapeutix (NASDAQ:OCUL) and its peers as we unravel the now-completed Q1 pharmaceuticals earnings season.\n\nThe pharmaceuticals sector develops, manufactures, and distributes drugs, benefiting from diversified portfolios of brand",
"image": "https://s.yimg.com/lo/mysterio/api/138F6D97F36E91FAF5A987068328BBB5C19D26C015D15C97A89B64F33F112090/subgraphmysterio/resizefill_w1200_h600;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fstockstory_922%2Fdd224e6a7af79b0a9a891704ffd12ece"
},
{
"title": "Is Ocular Therapeutix (OCUL) Still Undervalued Or Is AXPAXLI Hope Already Priced In?",
"url": "https://finance.yahoo.com/markets/stocks/articles/ocular-therapeutix-ocul-still-undervalued-011002548.html",
"source": "Yahoo! Finance",
"date": "2026-07-24T01:10:02Z",
"summary": "Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE.\n\nOcular Therapeutix (OCUL) has drawn investor attention after recent trading saw the stock close at $8.62, with returns under pressure over the past month and past 3",
"image": "https://s.yimg.com/lo/mysterio/api/815C9BB137C1765119389BB2FE6AB8C92B579126C032B10C69A0687ED3CF6985/subgraphmysterio/resizefill_w1200_h434;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fsimply_wall_st__316%2Ffd5474a7eee0c5f442903b68fe63249b"
},
{
"title": "Ocular Therapeutix Eyes Q4 AXPAXLI NDA After FDA Alignment",
"url": "https://finance.yahoo.com/healthcare/articles/ocular-therapeutix-eyes-q4-axpaxli-000233079.html",
"source": "Yahoo! Finance",
"date": "2026-07-23T00:02:33Z",
"summary": "Ocular Therapeutix (NASDAQ:OCUL) said it remains on track to submit a New Drug Application for AXPAXLI in wet age-related macular degeneration in the fourth quarter, after what Executive Chairman, President and CEO Dr. Pravin Dugel described as alignment with the U.S. Food and Dr",
"image": "https://s.yimg.com/lo/mysterio/api/B1E1A6839F510B9C3F9F229DF8C0997273B4F37EC75EDFD89F227947DD6DDFA2/subgraphmysterio/resizefill_w1200_h675;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fmarketbeat_955%2Fb42467ef9a84c745b117a9373766ddb9"
},
{
"title": "Diabetic Retinopathy Pipeline Insight 2026: Comprehensive Analysis of 50+ Companies and 55+ Drugs in Development",
"url": "https://www.globenewswire.com/news-release/2026/07/03/3321868/28124/en/Diabetic-Retinopathy-Pipeline-Insight-2026-Comprehensive-Analysis-of-50-Companies-and-55-Drugs-in-Development.html",
"source": "GlobeNewswire Inc.",
"date": "2026-07-03T13:59:00Z",
"summary": "A comprehensive pipeline analysis reveals over 50 companies developing 55+ drugs for diabetic retinopathy treatment. Key developments include Kodiak Sciences' Tarcocimab tedromer (Phase III anti-VEGF therapy), Vantage Biosciences' VX-01 (Phase II oral treatment), and Therini Bio'",
"image": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7"
},
{
"title": "Ocular Therapeutix\u2122 to Participate in July Scientific and Investor Conferences",
"url": "https://www.globenewswire.com/news-release/2026/07/01/3320488/0/en/Ocular-Therapeutix-to-Participate-in-July-Scientific-and-Investor-Conferences.html",
"source": "GlobeNewswire Inc.",
"date": "2026-07-01T11:00:00Z",
"summary": "Ocular Therapeutix announced its participation in multiple scientific conferences in July 2026, including the OIS Retina Innovation Summit and ASRS 44th Annual Meeting in Montreal. The company will present Phase 3 SOL-1 trial results for AXPAXLI (OTX-TKI), its investigational int",
"image": "https://ml.globenewswire.com/Resource/Download/20ee0f50-7288-4f81-8546-f2ad2050ddbf"
},
{
"title": "Ocular Therapeutix, Inc. (OCUL) Analyst/Investor Day Transcript",
"url": "https://seekingalpha.com/article/4915828-ocular-therapeutix-inc-ocul-analyst-investor-day-transcript",
"source": "Seeking Alpha",
"date": "2026-06-17 23:42:09",
"summary": "Ocular Therapeutix, Inc. (OCUL) Analyst/Investor Day Transcript",
"image": "https://images.financialmodelingprep.com/news/ocular-therapeutix-inc-ocul-analystinvestor-day-transcript-20260617.jpg"
},
{
"title": "Ocular Therapeutix Maps Regulatory Strategy For Lead Drug Program",
"url": "https://www.benzinga.com/news/health-care/26/06/53252720/ocular-therapeutix-maps-regulatory-strategy-for-lead-drug-program",
"source": "Benzinga",
"date": "2026-06-17 10:55:03",
"summary": "Ocular Therapeutix, Inc. (NASDAQ:OCUL) stock is trading higher on Wednesday as the company prepares for its Investor Day, where it will detail its plans for submitting a New Drug Application (NDA) for AXPAXLI.",
"image": "https://images.financialmodelingprep.com/news/ocular-therapeutix-maps-regulatory-strategy-for-lead-drug-program-20260617.jpg"
},
{
"title": "Ocular Therapeutix\u2122 Investor Day to Highlight U.S. FDA Alignment on AXPAXLI\u2122 NDA with Submission Planned for Fourth Quarter 2026",
"url": "https://www.globenewswire.com/news-release/2026/06/17/3313442/0/en/Ocular-Therapeutix-Investor-Day-to-Highlight-U-S-FDA-Alignment-on-AXPAXLI-NDA-with-Submission-Planned-for-Fourth-Quarter-2026.html",
"source": "GlobeNewsWire",
"date": "2026-06-17 08:45:00",
"summary": "Per May 2026 Type C meeting, AXPAXLI NDA for wet AMD to be based on SOL-1 Week 52 efficacy and safety plus interim SOL-R safety data",
"image": "https://images.financialmodelingprep.com/news/ocular-therapeutix-investor-day-to-highlight-us-fda-alignment-20260617.jpg"
},
{
"title": "Ocular Therapeutix vs. Prime Medicine: Which Healthcare Stock Is a Better Buy in 2026?",
"url": "https://www.fool.com/coverage/better-buy/2026/06/15/ocular-therapeutix-vs-prime-medicine-which-healthcare-stock-is-a-better-buy-in-2026/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-06-15T20:10:02Z",
"summary": "The article compares two biotech companies with different risk profiles: Ocular Therapeutix, which has commercial revenue from its Dextenza product and is preparing an FDA application for Axpaxli, versus Prime Medicine, which is developing early-stage Prime Editing gene therapy t",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F5d5d57f05229d5e553cc6e2f816603ec4ca01b17-1200x800.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "What This Fund\u2019s $14 Million Ocular Therapeutix Exit Could Signal for Investors",
"url": "https://www.fool.com/coverage/filings/2026/05/19/what-this-fund-s-usd14-million-ocular-therapeutix-exit-could-signal-for-investors/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-05-19T17:06:23Z",
"summary": "Saturn V Capital Management fully exited its position in Ocular Therapeutix, selling 1.5 million shares for approximately $14.34 million in Q1 2026. The exit comes as Ocular faces investor skepticism following lighter-than-expected Q1 revenue of $10.8 million and widened net loss",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F782b0b9f4f412d891de6f8f7670abc6b1a621e10-1401x1251.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Ocular Therapeutix\u2122 to Host Investor Day on June 17, 2026",
"url": "https://www.globenewswire.com/news-release/2026/04/22/3278789/0/en/Ocular-Therapeutix-to-Host-Investor-Day-on-June-17-2026.html",
"source": "GlobeNewswire Inc.",
"date": "2026-04-22T11:00:00Z",
"summary": "Ocular Therapeutix announced an Investor Day scheduled for June 17, 2026, in New York City with virtual access. The company also reported additional positive Week 52 data from its landmark SOL-1 Phase 3 trial of AXPAXLI in wet AMD, demonstrating robust disease control with sustai",
"image": "https://ml.globenewswire.com/Resource/Download/20ee0f50-7288-4f81-8546-f2ad2050ddbf"
},
{
"title": "Citizens reiterates Ocular Therapeutix stock rating on Dextenza sales By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/citizens-reiterates-ocular-therapeutix-stock-rating-on-dextenza-sales-93CH-4797852",
"source": "Investing.com",
"date": "2026-04-20T18:08:21Z",
"summary": "Investing.com - Citizens reiterated a Market Outperform rating and $34.00 price target on Ocular Therapeutix (NASDAQ:OCUL) shares. The stock currently trades at $9.16 with a market cap of $2.01 billion, down 24.5% year-to-date. According to InvestingPro data, analyst consensus st",
"image": "https://i-invdn-com.investing.com/news/moved_LYNXMPEM3Q0WG_1200_L.jpg"
},
{
"title": "Ocular Therapeutix\u2122 to Announce Topline Data for SOL-1 Phase 3 Superiority Trial in Wet AMD on Tuesday, February 17, 2026",
"url": "https://www.globenewswire.com/news-release/2026/02/13/3238349/0/en/Ocular-Therapeutix-to-Announce-Topline-Data-for-SOL-1-Phase-3-Superiority-Trial-in-Wet-AMD-on-Tuesday-February-17-2026.html",
"source": "GlobeNewswire Inc.",
"date": "2026-02-13T22:00:00Z",
"summary": "Ocular Therapeutix announced it will present topline results from its SOL-1 Phase 3 superiority trial of AXPAXLI (OTX-TKI) for wet age-related macular degeneration on February 17, 2026, with detailed data to follow at the Macula Society Annual Meeting. The company is advancing it",
"image": "https://ml.globenewswire.com/Resource/Download/20ee0f50-7288-4f81-8546-f2ad2050ddbf"
},
{
"title": "Corticosteroids Market Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031",
"url": "https://www.globenewswire.com/news-release/2026/01/26/3225321/28124/en/Corticosteroids-Market-Report-2026-Global-Industry-Size-Share-Trends-Opportunity-and-Forecast-2021-2031.html",
"source": "GlobeNewswire Inc.",
"date": "2026-01-26T09:51:00Z",
"summary": "The global corticosteroids market is projected to grow from USD 6.24 billion in 2025 to USD 8.45 billion by 2031 at a CAGR of 5.18%, driven by rising chronic diseases like asthma and COPD. However, safety concerns from prolonged usage and a shift toward biologics and localized th",
"image": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7"
}
]
Data:
[
{
"symbol": "OCUL",
"date": "2026-11-03",
"epsActual": null,
"epsEstimated": -0.36,
"revenueActual": null,
"revenueEstimated": 14280210,
"lastUpdated": "2026-08-17"
},
{
"symbol": "OCUL",
"date": "2026-08-03",
"epsActual": -0.35,
"epsEstimated": -0.39545,
"revenueActual": 13475000,
"revenueEstimated": 13201400,
"lastUpdated": "2026-08-17"
},
{
"symbol": "OCUL",
"date": "2026-05-05",
"epsActual": -0.41,
"epsEstimated": -0.32,
"revenueActual": 10785000,
"revenueEstimated": 12722180,
"lastUpdated": "2026-08-05"
},
{
"symbol": "OCUL",
"date": "2026-02-05",
"epsActual": -0.29,
"epsEstimated": -0.33,
"revenueActual": 13250000,
"revenueEstimated": 16128470,
"lastUpdated": "2026-05-05"
},
{
"symbol": "OCUL",
"date": "2025-11-04",
"epsActual": -0.37,
"epsEstimated": -0.39,
"revenueActual": 14544000,
"revenueEstimated": 16142430,
"lastUpdated": "2026-02-04"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "OCUL",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "OCUL",
"periods": [
{
"file_period": "202604a",
"settlement_date": "20260414",
"quantity_fails": 2378,
"price": 8.86
},
{
"file_period": "202604b",
"settlement_date": "20260424",
"quantity_fails": 3,
"price": 9.59
},
{
"file_period": "202606a",
"settlement_date": "20260605",
"quantity_fails": 3,
"price": 8.8
},
{
"file_period": "202606b",
"settlement_date": "20260630",
"quantity_fails": 137797,
"price": 9.9
},
{
"file_period": "202607a",
"settlement_date": "20260714",
"quantity_fails": 10381,
"price": 9.88
},
{
"file_period": "202607b",
"settlement_date": "20260729",
"quantity_fails": 35,
"price": 8.45
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "OCUL",
"filingDate": "2026-06-18",
"transactionDate": "2026-06-16",
"reportingCik": "0001700917",
"companyCik": "0001393434",
"transactionType": "G-Gift",
"securitiesOwned": 2547078,
"reportingName": "Dugel Pravin",
"typeOfOwner": "director, officer: See Remarks",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 50092,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1393434/000110465926075709/0001104659-26-075709-index.htm"
},
{
"symbol": "OCUL",
"filingDate": "2026-06-18",
"transactionDate": "2026-06-16",
"reportingCik": "0001700917",
"companyCik": "0001393434",
"transactionType": "G-Gift",
"securitiesOwned": 50092,
"reportingName": "Dugel Pravin",
"typeOfOwner": "director, officer: See Remarks",
"acquisitionOrDisposition": "A",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 50092,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1393434/000110465926075709/0001104659-26-075709-index.htm"
},
{
"symbol": "OCUL",
"filingDate": "2026-06-12",
"transactionDate": "2026-06-10",
"reportingCik": "0001354802",
"companyCik": "0001393434",
"transactionType": "A-Award",
"securitiesOwned": 100464,
"reportingName": "Warden Charles M",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 14000,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1393434/000110465926073589/0001104659-26-073589-index.htm"
},
{
"symbol": "OCUL",
"filingDate": "2026-06-12",
"transactionDate": "2026-06-10",
"reportingCik": "0001354802",
"companyCik": "0001393434",
"transactionType": "A-Award",
"securitiesOwned": 44000,
"reportingName": "Warden Charles M",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 44000,
"price": 8.74,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1393434/000110465926073589/0001104659-26-073589-index.htm"
},
{
"symbol": "OCUL",
"filingDate": "2026-06-12",
"transactionDate": "2026-06-10",
"reportingCik": "0001326192",
"companyCik": "0001393434",
"transactionType": "A-Award",
"securitiesOwned": 64000,
"reportingName": "Graves Adrienne L",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 14000,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1393434/000110465926073587/0001104659-26-073587-index.htm"
},
{
"symbol": "OCUL",
"filingDate": "2026-06-12",
"transactionDate": "2026-06-10",
"reportingCik": "0001326192",
"companyCik": "0001393434",
"transactionType": "A-Award",
"securitiesOwned": 44000,
"reportingName": "Graves Adrienne L",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 44000,
"price": 8.74,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1393434/000110465926073587/0001104659-26-073587-index.htm"
},
{
"symbol": "OCUL",
"filingDate": "2026-06-12",
"transactionDate": "2026-06-10",
"reportingCik": "0002104600",
"companyCik": "0001393434",
"transactionType": "A-Award",
"securitiesOwned": 68097,
"reportingName": "Robins Jason Shand",
"typeOfOwner": "officer: Chief Financial Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 15441,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1393434/000110465926073586/0001104659-26-073586-index.htm"
},
{
"symbol": "OCUL",
"filingDate": "2026-06-12",
"transactionDate": "2026-06-10",
"reportingCik": "0002104600",
"companyCik": "0001393434",
"transactionType": "A-Award",
"securitiesOwned": 14024,
"reportingName": "Robins Jason Shand",
"typeOfOwner": "officer: Chief Financial Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 14024,
"price": 8.74,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1393434/000110465926073586/0001104659-26-073586-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
"status",
"endpoint",
"provided",
"message"
],
"dark_pool": [
{
"ticker": "OCUL",
"executed_at": "2026-08-17T15:41:46.345000Z",
"size": 7000.0,
"price": 10.645,
"premium": 74515.0,
"volume": 7000.0,
"trade_code": " "
},
{
"ticker": "OCUL",
"executed_at": "2026-08-17T15:43:11.176000Z",
"size": 1000.0,
"price": 10.64,
"premium": 10640.0,
"volume": 1000.0,
"trade_code": "F"
},
{
"ticker": "OCUL",
"executed_at": "2026-08-17T15:43:11.176000Z",
"size": 922.0,
"price": 10.64,
"premium": 9810.08,
"volume": 922.0,
"trade_code": "F"
},
{
"ticker": "OCUL",
"executed_at": "2026-08-17T15:42:40.707000Z",
"size": 378.0,
"price": 10.66,
"premium": 4029.48,
"volume": 378.0,
"trade_code": " "
},
{
"ticker": "OCUL",
"executed_at": "2026-08-17T15:42:46.443000Z",
"size": 300.0,
"price": 10.665,
"premium": 3199.4999999999995,
"volume": 300.0,
"trade_code": " "
},
{
"ticker": "OCUL",
"executed_at": "2026-08-17T15:42:46.440000Z",
"size": 300.0,
"price": 10.669,
"premium": 3200.7000000000003,
"volume": 300.0,
"trade_code": " "
},
{
"ticker": "OCUL",
"executed_at": "2026-08-17T15:42:20.187000Z",
"size": 300.0,
"price": 10.67,
"premium": 3201.0,
"volume": 300.0,
"trade_code": "F"
},
{
"ticker": "OCUL",
"executed_at": "2026-08-17T15:42:05.412000Z",
"size": 300.0,
"price": 10.675,
"premium": 3202.5,
"volume": 300.0,
"trade_code": "F"
}
],
"ats": {
"symbol": "OCUL",
"date": "20260814",
"ats_volume": 0,
"total_volume": 631127,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260814",
"ats_ratio": 0.0
},
{
"date": "20260813",
"ats_ratio": 0.0
},
{
"date": "20260812",
"ats_ratio": 0.0
},
{
"date": "20260811",
"ats_ratio": 0.0
},
{
"date": "20260810",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "OCUL",
"days": [
{
"date": "2026-08-17",
"close": 10.665,
"vwap": 10.91,
"volume": 5188357,
"vwap_discount_pct": 2.31
},
{
"date": "2026-08-14",
"close": 10.04,
"vwap": 9.9,
"volume": 1634137,
"vwap_discount_pct": -1.36
},
{
"date": "2026-08-13",
"close": 10.1,
"vwap": 10.17,
"volume": 2584839,
"vwap_discount_pct": 0.68
},
{
"date": "2026-08-12",
"close": 10.23,
"vwap": 10.17,
"volume": 4006398,
"vwap_discount_pct": -0.57
},
{
"date": "2026-08-11",
"close": 9.76,
"vwap": 9.6,
"volume": 2180219,
"vwap_discount_pct": -1.67
}
],
"avg_vwap_discount_pct": -0.12,
"signal": "Neutral"
},
"options_flow": [
{
"nbbo_ask": "1.65",
"nbbo_bid": "1.05",
"size": 96,
"executed_at": "2026-08-17T14:34:28.308867Z",
"open_interest": 3,
"underlying_symbol": "OCUL",
"expiry": "2026-12-18",
"sector": "Healthcare",
"strike": "14",
"option_chain_id": "OCUL261218C00014000",
"underlying_price": "10.64",
"volume": 100,
"premium": "10080.00",
"price": "1.05",
"delta": "0.3793274320479918",
"implied_volatility": "0.823463465144501",
"option_type": "call"
}
],
"net_premium": {
"ticker": "OCUL",
"net_call_premium": "-24814.00",
"net_put_premium": "88940.00",
"call_premium": "214825.00",
"put_premium": "178449.00",
"bullish_premium": "131785.00",
"bearish_premium": "245539.00",
"put_call_ratio": "0.85911725367810967454",
"iv_rank": "6.9605",
"implied_move_perc": "0.140000",
"gex_ratio": "0.32852344025531561361",
"gex_net_change": "35463.6271",
"gex_call": "396176.2564",
"gex_put": "-130153.1867",
"gex_net": 266023.0697,
"gex_call_delta": "2644449.3058",
"gex_put_delta": "-380001.8841",
"gex_date": "2026-08-17"
},
"hot_chains": [
{
"underlying_symbol": "OCUL",
"expires": "2026-09-18",
"open_interest": 293,
"option_type": "put",
"delta": -0.526234276424614,
"ask_volume": 934,
"last_price": "1.00",
"implied_volatility": "0.674824014024323",
"gamma": 0.1915143086542186,
"avg_price": "1.2020381613183000867302688637",
"bid_volume": 219,
"nbbo_ask": "1.30",
"strike": "11",
"option_symbol": "OCUL260918P00011000",
"total_premium": "138595.00",
"iv": 0.656995697322251,
"volume": 1153,
"nbbo_bid": "1.00"
},
{
"underlying_symbol": "OCUL",
"expires": "2026-09-18",
"open_interest": 14654,
"option_type": "call",
"delta": 0.484929954006804,
"ask_volume": 218,
"last_price": "0.79",
"implied_volatility": "0.705195661992203",
"gamma": 0.1720392418037033,
"avg_price": "1.1424673202614379084967320256",
"bid_volume": 355,
"nbbo_ask": "0.80",
"strike": "11",
"option_symbol": "OCUL260918C00011000",
"total_premium": "69919.00",
"iv": 0.732430797413049,
"volume": 612,
"nbbo_bid": "0.75"
},
{
"underlying_symbol": "OCUL",
"expires": "2026-08-21",
"open_interest": 511,
"option_type": "call",
"delta": 0.1842688600211265,
"ask_volume": 101,
"last_price": "0.15",
"implied_volatility": "1.27582489606693",
"gamma": 0.2013827606848108,
"avg_price": "0.2204611650485436893203883493",
"bid_volume": 208,
"nbbo_ask": "0.20",
"strike": "12",
"option_symbol": "OCUL260821C00012000",
"total_premium": "9083.00",
"iv": 1.16022045660922,
"volume": 412,
"nbbo_bid": "0.05"
},
{
"underlying_symbol": "OCUL",
"expires": "2026-09-18",
"open_interest": 11198,
"option_type": "put",
"delta": -0.1648715652752113,
"ask_volume": 73,
"last_price": "0.22",
"implied_volatility": "0.697215879309158",
"gamma": 0.1211923880202687,
"avg_price": "0.3730930930930930930930930929",
"bid_volume": 189,
"nbbo_ask": "0.25",
"strike": "9",
"option_symbol": "OCUL260918P00009000",
"total_premium": "12424.00",
"iv": 0.647081870396004,
"volume": 333,
"nbbo_bid": "0.15"
},
{
"underlying_symbol": "OCUL",
"expires": "2026-08-21",
"open_interest": 1469,
"option_type": "call",
"delta": 0.420534975335717,
"ask_volume": 105,
"last_price": "0.34",
"implied_volatility": "1.020684391890065",
"gamma": 0.297691089617438,
"avg_price": "0.5220879120879120879120879121",
"bid_volume": 118,
"nbbo_ask": "0.40",
"strike": "11",
"option_symbol": "OCUL260821C00011000",
"total_premium": "14253.00",
"iv": 1.152519555257409,
"volume": 273,
"nbbo_bid": "0.30"
},
{
"underlying_symbol": "OCUL",
"expires": "2026-09-18",
"open_interest": 111,
"option_type": "put",
"delta": -0.3372058820065,
"ask_volume": 132,
"last_price": "0.50",
"implied_volatility": "0.692660052027113",
"gamma": 0.1736560206423464,
"avg_price": "0.6248404255319148936170212767",
"bid_volume": 47,
"nbbo_ask": "0.60",
"strike": "10",
"option_symbol": "OCUL260918P00010000",
"total_premium": "11747.00",
"iv": 0.6648001410508,
"volume": 188,
"nbbo_bid": "0.45"
},
{
"underlying_symbol": "OCUL",
"expires": "2026-09-18",
"open_interest": 518,
"option_type": "call",
"delta": 0.1469319797526683,
"ask_volume": 126,
"last_price": "0.16",
"implied_volatility": "0.899119403279983",
"gamma": 0.0760939864187756,
"avg_price": "0.2455639097744360902255639098",
"bid_volume": 7,
"nbbo_ask": "0.25",
"strike": "15",
"option_symbol": "OCUL260918C00015000",
"total_premium": "3266.00",
"iv": 0.948877350098266,
"volume": 133,
"nbbo_bid": "0.15"
},
{
"underlying_symbol": "OCUL",
"expires": "2026-12-18",
"open_interest": 124,
"option_type": "call",
"delta": 0.250585634022895,
"ask_volume": 0,
"last_price": "0.95",
"implied_volatility": "0.877665875296239",
"gamma": 0.066076431505249,
"avg_price": "0.9500000000000000000000000000",
"bid_volume": 104,
"nbbo_ask": "1.35",
"strike": "16",
"option_symbol": "OCUL261218C00016000",
"total_premium": "9880.00",
"iv": 0.777066745498383,
"volume": 104,
"nbbo_bid": "0.00"
}
],
"gamma_profile": {
"ticker": "OCUL",
"spot": 10.63,
"date": "2026-08-17",
"flip_point": 10.07,
"net_gex": 266023.07,
"call_walls": [
{
"strike": 11.0,
"gex": 198002.91
},
{
"strike": 10.0,
"gex": 90814.15
},
{
"strike": 20.0,
"gex": 34195.16
}
],
"put_walls": [
{
"strike": 9.0,
"gex": -94982.46
},
{
"strike": 8.0,
"gex": -16748.65
},
{
"strike": 10.0,
"gex": -7592.47
}
],
"by_strike": [
{
"strike": 1.0,
"call_gex": 0.0,
"put_gex": -0.0,
"net_gex": -0.0
},
{
"strike": 2.0,
"call_gex": 0.0,
"put_gex": -0.03,
"net_gex": -0.03
},
{
"strike": 3.0,
"call_gex": 25.64,
"put_gex": -843.61,
"net_gex": -817.96
},
{
"strike": 4.0,
"call_gex": 0.0,
"put_gex": -0.03,
"net_gex": -0.03
},
{
"strike": 5.0,
"call_gex": 81.12,
"put_gex": -321.01,
"net_gex": -239.89
},
{
"strike": 6.0,
"call_gex": 17.91,
"put_gex": -751.88,
"net_gex": -733.97
},
{
"strike": 7.0,
"call_gex": 76.94,
"put_gex": -3164.62,
"net_gex": -3087.68
},
{
"strike": 8.0,
"call_gex": 8682.73,
"put_gex": -16748.65,
"net_gex": -8065.92
},
{
"strike": 9.0,
"call_gex": 12081.99,
"put_gex": -94982.46,
"net_gex": -82900.47
},
{
"strike": 10.0,
"call_gex": 90814.15,
"put_gex": -7592.47,
"net_gex": 83221.68
},
{
"strike": 11.0,
"call_gex": 198002.91,
"put_gex": -4617.22,
"net_gex": 193385.69
},
{
"strike": 12.0,
"call_gex": 32862.79,
"put_gex": -331.34,
"net_gex": 32531.44
},
{
"strike": 13.0,
"call_gex": 4109.1,
"put_gex": -22.29,
"net_gex": 4086.82
},
{
"strike": 14.0,
"call_gex": 2097.35,
"put_gex": 0.0,
"net_gex": 2097.35
},
{
"strike": 15.0,
"call_gex": 7480.55,
"put_gex": -304.25,
"net_gex": 7176.3
},
{
"strike": 16.0,
"call_gex": 1722.8,
"put_gex": 0.0,
"net_gex": 1722.8
},
{
"strike": 17.0,
"call_gex": 1365.13,
"put_gex": -340.07,
"net_gex": 1025.06
},
{
"strike": 18.0,
"call_gex": 355.15,
"put_gex": -3.51,
"net_gex": 351.64
},
{
"strike": 19.0,
"call_gex": 4.8,
"put_gex": 0.0,
"net_gex": 4.8
},
{
"strike": 20.0,
"call_gex": 34195.16,
"put_gex": -46.64,
"net_gex": 34148.52
},
{
"strike": 22.0,
"call_gex": 844.32,
"put_gex": 0.0,
"net_gex": 844.32
},
{
"strike": 25.0,
"call_gex": 735.96,
"put_gex": -74.27,
"net_gex": 661.7
},
{
"strike": 30.0,
"call_gex": 619.74,
"put_gex": -8.84,
"net_gex": 610.9
}
]
},
"oi_changes": {
"net_call_oi_change": 434,
"net_put_oi_change": 122,
"top": [
{
"strike": "11",
"oi_change": 324,
"type": "call"
},
{
"strike": "8",
"oi_change": 63,
"type": "put"
},
{
"strike": "11",
"oi_change": 62,
"type": "call"
},
{
"strike": "9",
"oi_change": 59,
"type": "put"
},
{
"strike": "10",
"oi_change": 27,
"type": "call"
}
]
}
}
Data:
{
"vix": 14.55,
"sp500": 7748.5,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.48,
"hy_spread": 2.72,
"treasury": {
"date": "2026-08-14",
"month1": 3.79,
"month2": 3.81,
"month3": 3.86,
"month6": 3.95,
"year1": 3.98,
"year2": 4.17,
"year3": 4.24,
"year5": 4.36,
"year7": 4.51,
"year10": 4.68,
"year20": 5.25,
"year30": 5.25
},
"events": [
{
"title": "FOMC Meeting Minutes",
"currency": "USD",
"date": "2026-08-19",
"time_utc": "18:00",
"impact": "High",
"forecast": null,
"previous": null,
"actual": null,
"minutes_until": 3043
}
]
}
Data:
{
"days": 40,
"patterns": [
{
"name": "VWAP Touch",
"count": 40,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 40,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 40,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 39,
"pct": 98
},
{
"name": "Woodie Pivot Touch",
"count": 38,
"pct": 95
},
{
"name": "PDH/PDL Touch",
"count": 35,
"pct": 88
},
{
"name": "Gap Fill",
"count": 31,
"pct": 78
},
{
"name": "Open Retracement",
"count": 25,
"pct": 62
},
{
"name": "Darvas Box",
"count": 9,
"pct": 22
},
{
"name": "High Vol Open",
"count": 8,
"pct": 20
},
{
"name": "Power Hour",
"count": 6,
"pct": 15
}
]
}